PL363538A1 - Kompozycja farmaceutyczna na bazie makrolidów do stosowania miejscowo w okulistyce - Google Patents

Kompozycja farmaceutyczna na bazie makrolidów do stosowania miejscowo w okulistyce

Info

Publication number: PL363538A1
Authority: PL; Poland
Prior art keywords: macrolides; ophthalmology; pharmaceutical composition; topical application; composition based
Prior art date: 2001-04-12

Application number

PL02363538A

Other languages

English (en)

Other versions

PL204403B1 (pl

Inventor

Jacques Luyckx

Frederic Pilotaz

Original Assignee

Laboratoires Thea

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-12

Filing date

2002-04-11

Publication date

2004-11-29

2002-04-11 Application filed by Laboratoires Thea filed Critical Laboratoires Thea

2004-11-29 Publication of PL363538A1 publication Critical patent/PL363538A1/pl

2010-01-29 Publication of PL204403B1 publication Critical patent/PL204403B1/pl

Links

239000003120 macrolide antibiotic agent Substances 0.000 title 1
229940041033 macrolides Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
230000000699 topical effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Ophthalmology & Optometry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PL363538A 2001-04-12 2002-04-11 Kompozycja farmaceutyczna do leczenia infekcji oka przez miejscowe podawanie zawierająca antybiotyk makrolidowy, sposób jej przygotowania oraz zastosowanie azytromycyny PL204403B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0105114A FR2823441B1 (fr)	2001-04-12	2001-04-12	Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
PCT/FR2002/001263 WO2002083178A1 (fr)	2001-04-12	2002-04-11	Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie

Publications (2)

Publication Number	Publication Date
PL363538A1 true PL363538A1 (pl)	2004-11-29
PL204403B1 PL204403B1 (pl)	2010-01-29

Family

ID=8862340

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL363538A PL204403B1 (pl)	2001-04-12	2002-04-11	Kompozycja farmaceutyczna do leczenia infekcji oka przez miejscowe podawanie zawierająca antybiotyk makrolidowy, sposób jej przygotowania oraz zastosowanie azytromycyny

Country Status (30)

Country	Link
US (1)	US7064109B2 (pl)
EP (1)	EP1377316B1 (pl)
JP (2)	JP4558275B2 (pl)
KR (1)	KR100835002B1 (pl)
CN (1)	CN1496270B (pl)
AR (1)	AR034033A1 (pl)
AT (1)	ATE397460T1 (pl)
BR (1)	BRPI0208367B8 (pl)
CA (1)	CA2443728C (pl)
CY (1)	CY1108302T1 (pl)
CZ (1)	CZ300213B6 (pl)
DE (1)	DE60226962D1 (pl)
DK (1)	DK1377316T3 (pl)
EA (1)	EA008088B1 (pl)
EG (1)	EG23169A (pl)
ES (1)	ES2307754T3 (pl)
FR (1)	FR2823441B1 (pl)
HR (1)	HRP20030907B1 (pl)
HU (1)	HU230459B1 (pl)
MA (1)	MA27005A1 (pl)
MX (1)	MXPA03009349A (pl)
OA (1)	OA12462A (pl)
PA (1)	PA8543401A1 (pl)
PE (1)	PE20021082A1 (pl)
PL (1)	PL204403B1 (pl)
PT (1)	PT1377316E (pl)
SI (1)	SI1377316T1 (pl)
TN (1)	TNSN03091A1 (pl)
WO (1)	WO2002083178A1 (pl)
ZA (1)	ZA200307718B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2314354T3 (es) *	2004-11-09	2009-03-16	Novagali Pharma S.A.	Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo.
FR2884716B1 (fr) *	2005-04-22	2009-08-21	Thea Sa Lab	Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
JPWO2007074904A1 (ja) *	2005-12-28	2009-06-04	わかもと製薬株式会社	水性医薬組成物
BRPI0808410A2 (pt) *	2007-02-28	2015-06-23	Aciex Therapeutics Inc	Métodos e composições para normalizar secreções da glândula meibomiana
US20100158821A1 (en) *	2008-12-22	2010-06-24	Eastman Chemical Company	Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
CN101780105B (zh) *	2009-01-20	2011-09-28	沈阳兴齐制药有限公司	小牛血去蛋白提取物的滴眼液
EP2228058A1 (en)	2009-03-04	2010-09-15	Novagali Pharma S.A.	Anionic oil-in-water emulsion containing prostaglandins and uses thereof
US8106111B2 (en) *	2009-05-15	2012-01-31	Eastman Chemical Company	Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
EP2394636B1 (en) *	2010-05-28	2014-03-19	Novagali Pharma S.A.	Method for treating retinal conditions using an intraocular tamponade
EP2389939A1 (en)	2010-05-28	2011-11-30	Novagali Pharma S.A.	Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
US9044508B2 (en) *	2013-03-15	2015-06-02	Insite Vision Corporation	Concentrated aqueous azalide formulations
AU2017290256A1 (en) *	2016-06-29	2019-01-17	Otonomy, Inc.	Triglyceride otic formulations and uses thereof
PT3266446T (pt) *	2016-07-07	2019-01-30	Salvat Lab Sa	Composição oftálmica compreendendo óleo de rícino e triglicérido de cadeia média
CN115475248A (zh) *	2021-06-16	2022-12-16	云南拜奥泰克生物技术有限责任公司	一种新型药用甘油三酯溶剂及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1152644A (en) *	1966-07-01	1969-05-21	Abbott Lab	Stable Solutions of Erythromycin Free Base
JPS6468328A (en) *	1987-09-09	1989-03-14	Suntory Ltd	Anticorneoulcerative
JP2563336B2 (ja) *	1987-06-01	1996-12-11	エーザイ株式会社	角膜透過促進点眼剤
FR2746035B1 (fr) *	1996-03-15	1998-06-12		Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
EP0925789B2 (en) *	1997-12-02	2009-06-17	Pfizer Products Inc.	Use of azithromycin in the topical treatment of ocular infections
JP2000159659A (ja) *	1998-11-30	2000-06-13	Kazuo Tsubota	眼科用人工涙液
US6239113B1 (en) *	1999-03-31	2001-05-29	Insite Vision, Incorporated	Topical treatment or prevention of ocular infections

2001
- 2001-04-12 FR FR0105114A patent/FR2823441B1/fr not_active Expired - Lifetime
2002
- 2002-04-09 PA PA20028543401A patent/PA8543401A1/es unknown
- 2002-04-10 EG EG20020380A patent/EG23169A/xx active
- 2002-04-10 AR ARP020101319A patent/AR034033A1/es not_active Application Discontinuation
- 2002-04-11 HR HR20030907A patent/HRP20030907B1/xx not_active IP Right Cessation
- 2002-04-11 DE DE60226962T patent/DE60226962D1/de not_active Expired - Lifetime
- 2002-04-11 HU HU0303864A patent/HU230459B1/hu unknown
- 2002-04-11 PE PE2002000306A patent/PE20021082A1/es not_active Application Discontinuation
- 2002-04-11 MX MXPA03009349A patent/MXPA03009349A/es active IP Right Grant
- 2002-04-11 CA CA2443728A patent/CA2443728C/fr not_active Expired - Lifetime
- 2002-04-11 SI SI200230723T patent/SI1377316T1/sl unknown
- 2002-04-11 WO PCT/FR2002/001263 patent/WO2002083178A1/fr not_active Ceased
- 2002-04-11 BR BRPI0208367A patent/BRPI0208367B8/pt not_active IP Right Cessation
- 2002-04-11 AT AT02732804T patent/ATE397460T1/de active
- 2002-04-11 CZ CZ20032771A patent/CZ300213B6/cs not_active IP Right Cessation
- 2002-04-11 DK DK02732804T patent/DK1377316T3/da active
- 2002-04-11 PT PT02732804T patent/PT1377316E/pt unknown
- 2002-04-11 EP EP02732804A patent/EP1377316B1/fr not_active Expired - Lifetime
- 2002-04-11 KR KR1020037012372A patent/KR100835002B1/ko not_active Expired - Lifetime
- 2002-04-11 JP JP2002580979A patent/JP4558275B2/ja not_active Expired - Lifetime
- 2002-04-11 ES ES02732804T patent/ES2307754T3/es not_active Expired - Lifetime
- 2002-04-11 OA OA1200300246A patent/OA12462A/fr unknown
- 2002-04-11 EA EA200301108A patent/EA008088B1/ru not_active IP Right Cessation
- 2002-04-11 PL PL363538A patent/PL204403B1/pl unknown
- 2002-04-11 US US10/474,811 patent/US7064109B2/en not_active Expired - Lifetime
- 2002-04-11 TN TNPCT/FR2002/001263A patent/TNSN03091A1/fr unknown
- 2002-04-11 CN CN02806447XA patent/CN1496270B/zh not_active Expired - Lifetime
2003
- 2003-09-26 MA MA27325A patent/MA27005A1/fr unknown
- 2003-10-02 ZA ZA200307718A patent/ZA200307718B/en unknown
2008
- 2008-08-28 CY CY20081100927T patent/CY1108302T1/el unknown
2009
- 2009-10-08 JP JP2009234250A patent/JP5170780B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CZ300213B6 (cs)	2009-03-18
BRPI0208367B8 (pt)	2021-05-25
CY1108302T1 (el)	2014-02-12
EG23169A (en)	2004-06-30
JP5170780B2 (ja)	2013-03-27
CN1496270A (zh)	2004-05-12
CA2443728C (fr)	2011-01-04
JP2010043109A (ja)	2010-02-25
ZA200307718B (en)	2004-09-02
AR034033A1 (es)	2004-01-21
HUP0303864A3 (en)	2012-07-30
BR0208367A (pt)	2004-03-09
JP2004526763A (ja)	2004-09-02
EA200301108A1 (ru)	2004-04-29
ES2307754T3 (es)	2008-12-01
KR100835002B1 (ko)	2008-06-09
TNSN03091A1 (fr)	2005-12-23
CN1496270B (zh)	2010-05-26
EA008088B1 (ru)	2007-02-27
JP4558275B2 (ja)	2010-10-06
WO2002083178A1 (fr)	2002-10-24
FR2823441A1 (fr)	2002-10-18
HRP20030907B1 (hr)	2010-04-30
KR20030088466A (ko)	2003-11-19
HRP20030907A2 (en)	2004-02-29
SI1377316T1 (sl)	2008-10-31
DE60226962D1 (de)	2008-07-17
HUP0303864A2 (hu)	2004-03-01
US20040197340A1 (en)	2004-10-07
US7064109B2 (en)	2006-06-20
CZ20032771A3 (cs)	2004-01-14
ATE397460T1 (de)	2008-06-15
EP1377316B1 (fr)	2008-06-04
MXPA03009349A (es)	2004-11-12
PE20021082A1 (es)	2002-12-18
BR0208367B1 (pt)	2013-11-12
DK1377316T3 (da)	2008-09-22
MA27005A1 (fr)	2004-12-20
PT1377316E (pt)	2008-09-15
PL204403B1 (pl)	2010-01-29
EP1377316A1 (fr)	2004-01-07
FR2823441B1 (fr)	2004-09-10
HU230459B1 (hu)	2016-07-28
HK1065708A1 (zh)	2005-03-04
PA8543401A1 (es)	2003-01-24
OA12462A (fr)	2006-06-24
CA2443728A1 (fr)	2002-10-24

Publication	Publication Date	Title
AU2001271055A1 (en)	2002-05-02	Pharmaceutical composition improved in peroral absorbability
AU7645701A (en)	2002-01-30	Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides
IL152659A0 (en)	2003-06-24	Pharmaceutical composition
SI1524266T1 (sl)	2007-08-31	Farmacevtski sestavek
HUP0204555A3 (en)	2004-06-28	Pharmaceutical composition
AU2002302147A1 (en)	2003-06-12	Pharmaceutical composition
AU2002257582A1 (en)	2002-09-04	Pharmaceutical formulation
AU2002258221A1 (en)	2003-05-08	Medicinal composition
PL363538A1 (pl)	2004-11-29	Kompozycja farmaceutyczna na bazie makrolidów do stosowania miejscowo w okulistyce
AU2001290239A1 (en)	2002-04-02	Medicinal composition
IL154238A0 (en)	2003-09-17	Pharmaceutical composition
AU3586401A (en)	2001-09-17	Pharmaceutical composition
GB9902227D0 (en)	1999-03-24	Pharmaceutical composition for topical administration
AU2002354460A1 (en)	2003-07-09	Medicinal composition
AU2001278705A1 (en)	2002-02-25	Pharmaceutical composition
AU2002304524A1 (en)	2002-10-28	Pharmaceutical composition based on macrolides for topical application in ophthalmology
AU2001259564A1 (en)	2002-01-21	Pharmaceutical compositions and methods for use
AUPR529701A0 (en)	2001-06-21	Pharmaceutical composition
AU2001230490A1 (en)	2002-06-11	Pharmaceutical formulation
GB0002691D0 (en)	2000-03-29	Pharmaceutical composition
GB0101094D0 (en)	2001-02-28	Pharmaceutical composition
AU2002100921A4 (en)	2003-06-05	Pharmaceutical composition
AUPQ678400A0 (en)	2000-05-11	Pharmaceutical composition
AU2002339723A1 (en)	2003-04-07	Pharmaceutical composition comprising chito-oligomers
AU2001286181A1 (en)	2003-03-18	Pharmaceutical composition comprising (-)-secoisolariciresinol